India · Delayed Price · Currency is INR Kopran Company Description
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally.
The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations.
It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, sterile carbapenem, urological, neuromodulator, antidiabetic, pain management, neuromodular, gastroenterology, and cardiovascular.
In addition, the company offers drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others.
Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
| Country | India |
| Founded | 1958 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,024 |
| CEO | Surendra Somani |
Contact Details
Address: Parijat House Mumbai, 400018 India | |
| Phone | 91 22 4366 1111 |
| Website | kopran.com |
Stock Details
| Ticker Symbol | 524280 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Surendra Somani | Chief Executive Officer |
| Basant Soni | Chief Financial Officer |
| Ajit Jain | Chief Operating Officer |